Reduced contrast agent volume using a heart-rate dependent and free-breathing scanning protocol in coronary computed tomography angiography (CTA) for patients with chronic obstructive pulmonary disease (COPD)
- PMID: 39794706
- PMCID: PMC11721589
- DOI: 10.1186/s12872-024-04437-2
Reduced contrast agent volume using a heart-rate dependent and free-breathing scanning protocol in coronary computed tomography angiography (CTA) for patients with chronic obstructive pulmonary disease (COPD)
Abstract
Background: The personalized, free-breathing, heart rate-dependent computed tomography angiography (CTA) protocol can significantly reduce the utilization of contrast medium (CM). This proves especially beneficial for patients with chronic obstructive pulmonary disease (COPD) undergoing coronary artery CTA examinations.
Objective: The aim of this study was to evaluate the feasibility of a personalized CT scanning protocol that was tailored to patients' heart rate and free-breathing for coronary CTA of patients with COPD.
Methods: A total of 400 patients with COPD who need to undergo the coronary CTA were prospectively randomized into two groups (patients with vascular occlusion were excluded). Group A (n = 200) underwent CTA following a traditional protocol (70mL). The timing of the scans in Group B (n = 200) was determined according to the patient's HR and free-breathing (30mL).
Results: No difference was found between the two groups in the CT values of RCA, LA, or LCX; (p = 0.131, 0.195 and 0.116). Subjective ratings of image quality (Table 2) were not statistically different between the two groups (p = 0.825).
Conclusion: By adopting a heart-rate dependent and free-breathing protocol, the contrast medium volume were reduced in coronary CTA for patients with COPD, while the image quality was remained comparable to those acquired with routine CTA protocol.
Keywords: COPD; Coronary CTA; HR-based protocol; Low volume of contrast medium.
© 2024. The Author(s).
Conflict of interest statement
Declarations. Ethical approval: This study was approved by the Ethics Committee of the Central Hospital Affiliated to Shandong First Medical University(approval number: JNCN2022-057, date of the approval: December in 2022), all methods were performed in accordance with the relevant guidelines and regulations. Informed consent: All participants provided written informed consent prior to enrollment. Competing interests: The authors declare no competing interests.
Figures
References
-
- Vestbo J. COPD: definition and phenotypes. Clin Chest Med. 2014;35:1–6. 10.1016/j.ccm.2013.10.010. - PubMed
-
- Williams MC, Murchison JT, Edwards LD, Agustí A, Bakke P, Calverley PMA, Celli B, Coxson HO, Crim C, Lomas DA, Miller BE, Rennard S, Silverman EK, Tal-Singer R, Vestbo J, Wouters E, Yates JC, van Beek EJR, Newby DE, MacNee W. Evaluation of COPD longitudinally to identify predictive surrogate endpoints (ECLIPSE) investigators, coronary artery calcification is increased in patients with COPD and associated with increased morbidity and mortality. Thorax. 2014;69:718–23. 10.1136/thoraxjnl-2012-203151. - PubMed
-
- Bade BC, DeRycke EC, Skanderson M, Crothers K, Haskell S, Bean-Mayberry B, Cain HC, Brandt C, Bastian LA, Akgün KM. Underutilization of pulmonary function testing in Veterans Hospitalized for Chronic Obstructive Pulmonary Disease Exacerbation: who are we missing? COPD. 2020;17:15–21. 10.1080/15412555.2019.1711036. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
